Vascular therapies represent an alternative to traditional invasive surgical techniques for the treatment of disease such as coronary artery disease. These procedures improve patient comfort by reducing pain and risk as well as yielding quicker recovery at lower cost.
Engineered polymer resins from Lubrizol LifeSciences are well suited for use in endovascular medical devices (used in the treatment of cardiovascular, peripheral vascular and neurovascular diseases) because of their long history of proven biocompatibility and indwelling softening characteristics. Lubrizol polymers have been used in vascular applications for more than 30 years.
Potential vascular applications conducive to Lubrizol polymer usage include: